186 related articles for article (PubMed ID: 3161209)
21. An inhibitor of plasminogen activator produced by tumour cell fusion hybrids.
Badenoch-Jones P; Ramshaw IA; Grant A
Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():343-52. PubMed ID: 2933023
[TBL] [Abstract][Full Text] [Related]
22. Interfering factors in the assay of plasminogen activators by the fibrin plate method. Occurrence of different inhibitors against tissue plasminogen activator and urokinase.
Wijngaards G
Thromb Haemost; 1979 May; 41(3):590-600. PubMed ID: 111368
[TBL] [Abstract][Full Text] [Related]
23. Properties of a partially purified preparation of a circulating plasminogen activator.
Ogston D; Bennett B; Mackie M
Thromb Res; 1976 Mar; 8(3):275-84. PubMed ID: 131386
[No Abstract] [Full Text] [Related]
24. Inhibition of plasminogen activator associated with chronic granulomatous inflammation.
Goldstein SM; Izaki S; Epstein WL
Thromb Res; 1979; 16(5-6):727-35. PubMed ID: 160627
[No Abstract] [Full Text] [Related]
25. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of the plasminogen activator urokinase by alpha-tocopherol.
Ogston D
Acta Haematol; 1982; 67(2):114-8. PubMed ID: 6801892
[TBL] [Abstract][Full Text] [Related]
27. Interaction of a plasmin A-chain/t-PA B-chain hybrid enzyme with plasma inhibitors in vivo and in vitro.
Wilson S; Chamberlain P; Dodd I; Esmail A; Robinson JH
Thromb Haemost; 1990 Jun; 63(3):459-63. PubMed ID: 1698316
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor.
Chapman HA; Stone OL
Biochem J; 1985 Aug; 230(1):109-16. PubMed ID: 2932100
[TBL] [Abstract][Full Text] [Related]
29. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
Lijnen HR; Uytterhoeven M; Collen D
Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cells.
Coleman PL; Patel PD; Cwikel BJ; Rafferty UM; Sznycer-Laszuk R; Gelehrter TD
J Biol Chem; 1986 Mar; 261(9):4352-7. PubMed ID: 2936742
[TBL] [Abstract][Full Text] [Related]
32. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
Crutchley DJ; Conanan LB
J Biol Chem; 1986 Jan; 261(1):154-9. PubMed ID: 3079753
[TBL] [Abstract][Full Text] [Related]
33. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
Stephens R; Leung KC; Pöllänen J; Salonen EM; Vaheri A
J Immunol Methods; 1987 Dec; 105(2):245-51. PubMed ID: 3121752
[TBL] [Abstract][Full Text] [Related]
34. Isolation and characterization of alpha2-plasmin inhibitor from human plasma. A novel proteinase inhibitor which inhibits activator-induced clot lysis.
Moroi M; Aoki N
J Biol Chem; 1976 Oct; 251(19):5956-65. PubMed ID: 134998
[TBL] [Abstract][Full Text] [Related]
35. Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators.
Golder JP; Stephens RW
Eur J Biochem; 1983 Nov; 136(3):517-22. PubMed ID: 6416839
[TBL] [Abstract][Full Text] [Related]
36. The inhibition of tissue activator and urokinase by human plasma.
Walker JE; Ogston D
Thromb Haemost; 1982 Jun; 47(3):265-8. PubMed ID: 6180497
[TBL] [Abstract][Full Text] [Related]
37. Fatty streaks and fibrous plaques in human aorta show increased plasminogen activator activity.
Smokovitis A; Kokolis N; Alexaki-Tzivanidou E
Haemostasis; 1988; 18(3):146-53. PubMed ID: 2972593
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of the inhibition by plasminogen activator inhibitor 2 of urokinase isolated from human urine and recombinant microorganisms. Further evidence for correct tertiary structure of recombinant urokinase.
Cramer J; Steffens G; Günzler WA; Hess V; Flohé L
Arzneimittelforschung; 1988 Aug; 38(8):1196-8. PubMed ID: 3143371
[TBL] [Abstract][Full Text] [Related]
39. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
Collen D
Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
[TBL] [Abstract][Full Text] [Related]
40. Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma.
Kruithof EK; Tran-Thang C; Ransijn A; Bachmann F
Blood; 1984 Oct; 64(4):907-13. PubMed ID: 6434006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
